Clinical Trial Update: Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial [Phase 3]

View source ↗

Summary

A Phase 3 trial called INSIGHT is evaluating immunotherapy after surgery for people with early-stage non-small cell lung cancer who have no remaining cancer aft…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 | Phase 3 | Status: RECRUITING